SEC Tracker
Get the app

Edgewise Therapeutics EWTX

Christopher Nathan Martin - Insider ownership filing (3)

Christopher Nathan Martin, new insider at EWTX

Form
3
Filed
Importance
Routine
  1. Insider ownership filing (3)
  2. Reports beneficial ownership changes

Written from the Form 3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Edgewise Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Innoviva INVA public float $1.3B, Jun 30, 2025
  2. Mannkind MNKD public float $1.1B, Jun 30, 2025
  3. Schrodinger SDGR public float $1.1B, Jun 30, 2025
  4. Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
  5. Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.